federal_register: 2024-03296
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03296 | Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Extension of Comment Period | Notice | The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that published in the Federal Register of December 22, 2023. In that notice, FDA requested comments on the draft guidance for industry entitled, "Master Protocols for Drug and Biological Product Development." The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. | 2024-02-16 | 2024 | 2 | https://www.federalregister.gov/documents/2024/02/16/2024-03296/master-protocols-for-drug-and-biological-product-development-draft-guidance-for-industry-extension | https://www.govinfo.gov/content/pkg/FR-2024-02-16/pdf/2024-03296.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that published in the Federal Register of December 22, 2023. In that notice, FDA requested comments on the draft guidance for industry... |